Disclosing a CEO’s Illness: Privacy vs. Transparency

by Parker Poe Adams & Bernstein LLP

From time to time, a prominent CEO’s illness makes its way into the news and highlights once again one of disclosure’s trickiest issues. Most recently, Jamie Dimon, Chairman and CEO of JPMorgan Chase, disclosed that he has been diagnosed with throat cancer. This immediately became a top business news story, which is understandable given his prominence in the financial industry and importance to JPMorgan Chase. His announcement once more begs these age-old questions: what disclosure is required, what disclosure is appropriate even if not required and what disclosure is unnecessarily intrusive?

Thankfully, this is an issue most of us do not have to wrestle with very often, and certainly everyone wishes Mr. Dimon a speedy recovery. But CEOs are human, too, and they get sick just like the rest of us. Therefore, these questions are bound to arise from time to time, and it’s good not to be blindsided when they do.

Sometimes you read things like this quote from The New York Times: “Executives have no real legal obligation to tell the world they are sick.” (See, A Fine Line In Revealing The Illness of the C.E.O., July 3, 2014.) However, although there is no rule specifically requiring such disclosure, that statement is not accurate for CEOs of most public companies.

Instead, if the illness is such that it might reasonably be expected to materially impact the CEO’s ability to carry out his or her job, and assuming that the CEO is material to the company’s performance (which most shareholders would like to believe to be the case), then the CEO has a duty to report his or her illness to the board of directors in as much detail as will allow it to make an informed decision about whether, when and how disclosure should be made.

Of course, these things are not clear cut, and the CEO’s right to privacy must be taken seriously. It is not necessary, for example, to include a detailed medical report or even necessarily to disclose the exact nature of the illness in all circumstances. It seems to me that the degree of detail is as much a function of the CEO’s personality as it is pure disclosure analysis.

Arguably, Mr. Dimon provided more detail in his announcement than was necessary. He began by saying he had been diagnosed with throat cancer, his prognosis is excellent and his condition is curable. He also said his treatment would curtail his travel for approximately eight weeks, but he expects to remain actively involved in the company’s business during that time. All of that sounds forthcoming, was helpful from the market’s perspective and probably was about what was required under a materiality analysis.

Less necessary were the details Mr. Dimon provided about the type of medical tests he had taken, the location of his cancer, the name of his hospital and the specific form of treatment. However, he obviously wanted to provide more than minimal information, and there is nothing wrong with that. JPMorgan Chase received kudos for the transparency of the disclosure and everyone seems to feel they have the whole story, which may be reason enough to go beyond the minimum if the CEO is comfortable doing so.

This is in stark contrast to Apple’s now well-parsed, and frequently criticized, disclosures regarding Steve Jobs’ illness. One of several examples occurred some five years after Mr. Jobs had been diagnosed with pancreatic cancer and appeared wan at a public appearance. After that appearance, a company spokesperson said that Mr. Jobs had “a common bug. […] He’s been on antibiotics and getting better…. That’s all there is to it.” While it’s not my place to question the accuracy of this or other statements or decisions made during what had to have been an extremely difficult time, the market reacted poorly to what it perceived to be an intentional lack of transparency regarding the health of the iconic leader of one of the nation’s largest companies. (Two separate SEC inquiries into Apple’s disclosures were closed without action.)

Warren Buffet, who underwent prostate-related surgery himself three years later, summed it up pretty well, as he is wont to do, back in 2009 when addressing Apple’s disclosures:

 “If I have any serious illness, or something coming up of an important nature such as an operation or anything like that, I think the thing to do is just tell Berkshire shareholders about it. I work for them. Some people might think I’m important to the company. […] So it’s a material fact.”

So, while this issue is far from simple, it’s inaccurate to say that the CEO’s privacy is paramount or that the rules do not require disclosure. Any time there is a reasonable possibility that the CEO’s (or perhaps another key executive’s) performance could be materially impacted by a pending illness, some amount of accurate, forthcoming disclosure is likely to be required.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Parker Poe Adams & Bernstein LLP | Attorney Advertising

Written by:

Parker Poe Adams & Bernstein LLP

Parker Poe Adams & Bernstein LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.